Olmesartan vs losartan
Pro Research Analysisby 
Searched over 200M research papers
Antihypertensive Efficacy: Olmesartan vs Losartan
Multiple studies have compared the blood pressure-lowering effects of olmesartan and losartan in patients with hypertension. Several randomized controlled trials and meta-analyses consistently show that olmesartan provides greater reductions in both systolic and diastolic blood pressure compared to losartan. For example, one study found that olmesartan led to a significantly greater reduction in diastolic blood pressure than losartan at the end of the treatment period 1567+2 MORE. Another meta-analysis confirmed that olmesartan was more effective than losartan in lowering both systolic and diastolic blood pressure, with no increase in adverse events 910. However, some studies found no statistically significant difference in overall effectiveness between the two drugs, suggesting that both are effective options for hypertension management 248.
Blood Pressure Control and Duration of Effect
Olmesartan not only reduces blood pressure more effectively but also maintains its antihypertensive effect for a longer duration. Studies using 24-hour ambulatory blood pressure monitoring showed that olmesartan had a more durable effect throughout the day compared to losartan, with higher trough-to-peak ratios, indicating more consistent blood pressure control 58. This suggests that olmesartan may provide better round-the-clock blood pressure management.
Safety and Tolerability Comparison
Both olmesartan and losartan are generally well tolerated, with similar rates of mild and transient adverse events reported in clinical trials 2456+3 MORE. Large network meta-analyses and individual studies found no significant difference in the incidence of adverse effects between the two drugs, and both are considered safe for long-term use in patients with mild to moderate hypertension 2458+2 MORE.
Cost-Effectiveness and Economic Considerations
Economic evaluations have shown that olmesartan may be a more cost-effective option compared to losartan. In a study conducted in Spain, olmesartan was associated with a higher proportion of patients achieving controlled blood pressure and a lower mean cost per patient, making it a dominant option from a healthcare system perspective .
Summary of Comparative Findings
- Efficacy: Olmesartan generally provides greater reductions in blood pressure than losartan, with more patients reaching target blood pressure levels 1567+2 MORE.
- Duration: Olmesartan offers more consistent 24-hour blood pressure control 58.
- Safety: Both drugs have similar safety profiles and are well tolerated 2456+3 MORE.
- Cost: Olmesartan may be more cost-effective in some healthcare settings .
Conclusion
Overall, olmesartan is often more effective than losartan in lowering blood pressure and maintaining consistent control throughout the day, while both drugs have similar safety profiles. Olmesartan may also offer economic advantages in certain settings. Both medications remain viable options for treating hypertension, but olmesartan may be preferred when greater blood pressure reduction and sustained control are desired.
Sources and full results
Most relevant research papers on this topic